MEDIPHARM LABS CORP COM (MEDIF)
Institutional ownership reported to the SEC as of Q2 2026, across 15 quarters.
1
Reporting holders
$10
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| GAMMA Investing LLC | $10 | 200 | 0.00% | 8q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $10 | 200 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $9 | 200 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $10 | 200 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $11 | 200 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 1 | $10 | 200 | 0 | 0 | 0 | 0.0% |
| Q1 2025 | 1 | $13 | 200 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 1 | $8 | 200 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 1 | $10 | 200 | 1 | 0 | 0 | 0.0% |
| Q3 2023 | 1 | $7 | 128 | 1 | 0 | 0 | 0.0% |
| Q4 2020 | 1 | $355.0K | 670,008 | 0 | 1 | 0 | 0.0% |
| Q3 2020 | 1 | $485.0K | 551,454 | 0 | 1 | 0 | 0.0% |
| Q2 2020 | 2 | $539.0K | 468,734 | 1 | 1 | 0 | 0.0% |
| Q1 2020 | 1 | $690.0K | 433,674 | 0 | 1 | 0 | 0.0% |
| Q4 2019 | 1 | $1.2M | 397,028 | 0 | 0 | 0 | 0.0% |
| Q2 2019 | 1 | $40.0K | 10,000 | 1 | 0 | 0 | 0.0% |